Renaissance Capital logo

CAMP News

US IPO Weekly Recap: Active IPO market continues with KinderCare and trio of biotech deals

KLC

Four IPOs each raised at least $75 million this week as the Fall IPO market continued to hum along, while one company postponed its deal. Early childhood education (ECE) provider KinderCare (KLC) priced just below the midpoint of the range...read more

RNA biotech CAMP4 Therapeutics prices IPO below the range at $11; adds shares to keep deal size at $75 million

CAMP4 Therapeutics logo

CAMP4 Therapeutics, a clinical-stage biotech developing RNA-based therapies to target genetic diseases, raised $75 million by offering 6.8 million shares at $11, below the range of $14 to $16. The Cambridge, MA-based company sold 1.8 million more shares than...read more

Genetic disease biotech CAMP4 Therapeutics sets terms for $75 million IPO

CAMP4 Therapeutics logo

CAMP4 Therapeutics, a clinical-stage biotech developing RNA-based therapies to target genetic diseases, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16...read more

US IPO Weekly Recap: 2 microcaps list as pipeline gets a big boost

GLE

Two small IPOs and two SPACs debuted this past week. Seven IPOs and three SPACs submitted initial filings. Hong Kong-based ICT solutions provider Global Engine Group (GLE) priced its downsized IPO at the bottom of the range to raise $8...read more